Repatha 140 MG/ML sureclickml

Ended Awarded

Contract number
SPE2DB25FHHYX
Awardee
Awarding agency
Obligated
$17,391

Award facts

Contract value 100% obligated
$17,390.89 Current and potential, with all options
Completion date 100% complete
Current and potential, with all options
NAICS code
424210 Drugs and Druggists' Sundries Merchant Wholesalers
PSC
6505 Drugs And Biologicals
Set-aside
No set-aside
Competition
Full and Open Competition Negotiated Proposal / Quote
Pricing
Firm Fixed Price
Place of performance
Conshohocken, PA 19428, USA

Award details come from SAM.gov/FPDS.

About this award

The Defense Logistics Agency awarded a delivery order valued at $17,390.89 to AmerisourceBergen Drug Corp for Repatha 140 mg/ml SureClick auto-injectors, with performance in Conshohocken, Pennsylvania and completion targeted for July 31, 2025. This competitively awarded, firm fixed-price contract contains no set-aside designation and represents a child order under AmerisourceBergen's larger Indefinite Delivery Contract with DLA Troop Support Medical (SPE2DX), a $999.99 billion global pharmaceutical support vehicle running through December 2026. Repatha is a PCSK9 inhibitor indicated for cholesterol management in patients at high cardiovascular risk, demonstrating the breadth of specialty pharmaceutical products the company supplies to federal healthcare systems.

As a major pharmaceutical distributor and critical vendor for military and veteran healthcare procurement, AmerisourceBergen delivers an extensive portfolio of brand-name and generic medications, vaccines, and medical devices across multiple therapeutic domains to the Defense Health Agency, U.S. Coast Guard, and other government healthcare systems. The company's consistent receipt of competitively awarded delivery orders through DLA reflects its established capability to meet federal medical supply requirements. The DLA Troop Support Medical contract vehicle enables flexible pharmaceutical sourcing for military healthcare programs worldwide, with the agency planning to establish next-generation Pharmaceutical Prime Vendor Global Program Generation V contracts involving multiple regional awards and contractors.

Quick answers

Who was awarded contract SPE2DB25FHHYX?

SPE2DB25FHHYX was awarded to Amerisourcebergen Drug Corp by Defense Logistics Agency (Department of Defense) on July 30, 2025.

How much is contract SPE2DB25FHHYX worth?

The government has obligated $17,391 on SPE2DB25FHHYX.

Is contract SPE2DB25FHHYX an order under another contract?

Yes. SPE2DB25FHHYX is a delivery order under SPE2DB24D2208, an indefinite delivery contract.

Was contract SPE2DB25FHHYX competed?

The extent of competition for SPE2DB25FHHYX was full and open competition.

On GovTribe

See this award's full record

  • Every transaction and funding action
  • The awardee's other awards and teaming partners
  • Similar awards and recompete opportunities
  • Ask GovTribe AI about this award